New eczema drug TRB-061 enters first human safety trials
Symptom relief
Recruiting now
This study tests an experimental drug called TRB-061 in healthy adults and people with moderate-to-severe atopic dermatitis (eczema). The main goal is to check if the drug is safe and how the body handles it. Participants receive either the drug or a placebo as injections under t…
Phase: PHASE1 • Sponsor: TRex Bio, Inc. • Aim: Symptom relief
Last updated May 18, 2026 11:59 UTC